Icon

VILTEPSO (nda212154)- (250MG/5ML (50MG/ML))

VILTOLARSEN NIPPON SHINYAKU
250MG/5ML (50MG/ML)
No No
2031-Aug-31 2025-Aug-12
None None
None No
VILTEPSO is an antisense oligonucleotide indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 53 skipping.
0 0 0
Total Other Developers None
Drugs with Suitability No
250MG/5ML (50MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.